Hereditary Genetic Testing Market

Hereditary genetic testing has grown significantly since the technology was first commercialized, but it is important to quantify that growth and describe future trends. The unmet clinical needs for better tools to predict, diagnose, treat, and monitor disease are acting as significant factors driving the growth of the sequencing industry. Whole-genome and exome sequencing remain relatively costly requiring initial equipment investment, specialized workforce requirements, and time-intensive variant interpretation.
Hereditary Genetic Testing Market contains market size and forecasts of Hereditary Genetic Testing in Global, including the following market information:
Global Hereditary Genetic Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Hereditary Genetic Testing market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oncology Genetic Testing Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Hereditary Genetic Testing include Agilent Technologies, Inc, Ambry Genetics, Beijing Genomics Institute (BGI), CENTOGENE AG, Eurofins Scientific SE, F. Hoffmann-La Roche Ltd, Inc, Illumina, Inc, Laboratory Corporation of America Holdings and Myriad Genetics, Inc, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Hereditary Genetic Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hereditary Genetic Testing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Hereditary Genetic Testing Market Segment Percentages, by Type, 2021 (%)
Oncology Genetic Testing
Cardiology Genetic Testing
Neurology Genetic Testing
Global Hereditary Genetic Testing Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Hereditary Genetic Testing Market Segment Percentages, by Application, 2021 (%)
Academic and Research
Clinical Diagnostics
Drug Discovery
Monitoring and Screening
Global Hereditary Genetic Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Hereditary Genetic Testing Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hereditary Genetic Testing revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Hereditary Genetic Testing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Agilent Technologies, Inc
Ambry Genetics
Beijing Genomics Institute (BGI)
CENTOGENE AG
Eurofins Scientific SE
F. Hoffmann-La Roche Ltd, Inc
Illumina, Inc
Laboratory Corporation of America Holdings
Myriad Genetics, Inc
PerkinElmer, Inc
Quest Diagnostics Incorporated
Thermo Fisher Scientific Inc